Adult Dosing

Dermatitis

Topical powder

• Apply on the affected area(s) qd-tid PRN
• Dissolve 1-3 packets of powder in a pint (16 Oz) of cool or warm water; stir until fully dissolved

Topical solution

• Apply on the affected area(s) qd-tid PRN
• Apply aluminum acetate solution topically to the affected area of the skin as a wet dressing, compress, or as a soak for 15-30 minutes PRN
• 1:40 sol is 0.14% aluminum acetate
• Refer package insert for reconstitution and dilution of topical solution

Topical gel

• Apply on dry, open, or abraded skin as needed

Pediatric Dosing

Dermatitis

Topical powder

• Apply on the affected area(s) qd-tid PRN
• Dissolve 1-3 packets of powder in a pint (16 Oz) of cool or warm water; stir until fully dissolved

Topical solution

• Apply on the affected area(s) qd-tid PRN
• Apply aluminum acetate solution topically to the affected area of the skin as a wet dressing, compress, or as a soak for 15-30 minutes PRN
• 1:40 sol is 0.14% aluminum acetate
• Refer package insert for reconstitution and dilution of topical solution

Topical Gel

• >2 yrs: Apply on dry, open, or abraded skin as needed

• Temporarily relieves:
• Minor skin irritations due to insect bites, athlete's foot; poison ivy, poison oak, or poison sumac; rashes due to cosmetics, detergents, or jewelry
• Swelling associated with minor bruises
• Acne, eczema, diaper rash, pruritus ani
• Itching, particularly useful on wet or weeping lesions

• Indicated for reducing foot sweat

• Hypersensitivity to any of the ingredients of the product

• N/A

Renal Dose Adjustment

• Renal impairment: Dose adjustments not defined

Hepatic Dose Adjustment

• Hepatic impairment: Dose adjustments not defined

See Supplemental Patient Information

• Indicated for external use only
• Avoid contact with the eyes; if contact occurs, rinse thoroughly with water
• Do not cover compress or wet dressing with plastic to prevent evaporation. Prolonged soaking may result in excessive drying of the skin
• Discontinue use and consult a clinician if condition worsens or symptoms persist for >1 week
• Keep this product out of reach of children. If swallowed, immediately seek medical help or contact a Poison Control Center
• Astringent action of aluminum acetate may be reduced when used concurrently with soap

Supplemental Patient Information

• Advise patients to avoid contact with the eyes

Pregnancy Category:NR

Breastfeeding: It is unknown whether topical aluminum acetate is excreted into breast milk.

• DERM: Local skin irritation, inflammation, dryness

• Astringent; constricts blood vessels, causes contraction or shrinkage of local tissues, reduces fluid secretions and relieves itching and inflammation
• Minimal systemic absorption
• Metabolism: Unknown; CYP450: Unknown
• Excretion: Unknown
• Half-life: Unknown

US Trade Name(s)

• Domeboro
• Modified Burow's solution
• TriCalm

US Availability

Domeboro

• OTC PWDR: 0.14%/pkt

Modified Burow's solution

• OTC SOLN: 0.14%

TriCalm

• OTC GEL: 0.2%

Canadian Trade Name(s)

• N/A

Canadian Availability

• N/A

UK Trade Name(s)

• N/A

UK Availability

• N/A

Australian Trade Name(s)

• Only generic available

Australian Availability

aluminum acetate (generic)

• OTC LOTN: 200 mL

Dermatologic

Other Dermatologics

Miscellaneous Agents